MASS
908 Devices Inc
NASDAQ: MASS · HEALTHCARE · MEDICAL DEVICES
$6.83
+5.08% today
Updated 2026-04-30
Market cap
$251.94M
P/E ratio
—
P/S ratio
4.48x
EPS (TTM)
$-0.93
Dividend yield
—
52W range
$4 – $9
Volume
0.3M
908 Devices Inc (MASS) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$6.83
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$15.66
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.1B | $0.1B | $0.1B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 34.70%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.